| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $65,744,650 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01EY017863 | Control of Photoreceptor Metabolism | 001 | 15 | NIH | 1/15/2025 | $441,250 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01GM152641 | The mechanism of extra-visual circadian photoentrainment in mammals | 000 | 2 | NIH | 12/16/2024 | $368,743 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM152106 | New approaches for investigating the causes and consequences of cellular heterogeneity | 001 | 2 | NIH | 1/24/2025 | $527,871 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K99DA059617 | Endocannabinoid modulation of behavioral engagement via an aPVT-NAc circuit | 000 | 2 | NIH | 12/19/2024 | $174,625 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH134882 | Safety Planning and Cognitive Behavioral Therapy for Adolescent Suicide Prevention in Mozambique: A Hybrid Effectiveness/Implementation Cluster Randomized Trial | 000 | 2 | NIH | 2/13/2025 | $545,383 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35HL171342 | Molecular and Cellular Regulation of Vascular Calcification | 000 | 2 | NIH | 1/3/2025 | $941,922 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HL161829 | Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes | 000 | 4 | NIH | 1/24/2025 | $808,164 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DK130815 | Therapeutic bubble tea: Preventing the formation of uremic toxins with hydrogel immobilized microbes | 000 | 4 | NIH | 12/23/2024 | $392,480 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31AI179043 | The role of antigen-independent T cell activation in controlling M. tuberculosis infection | 000 | 2 | NIH | 12/30/2024 | $28,224 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01EY029601 | Spatiotemporal representation in ventral visual pathway | 000 | 5 | NIH | 12/4/2024 | $457,750 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258352 | Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging | 001 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258352 | Comparative-Effectiveness of Pretreatment Lung Cancer Nodal Staging | 000 | 4 | NIH | 12/20/2024 | $541,223 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM148137 | Structural energetics of voltage- and ligand-dependent gating in ion channels | 001 | 3 | NIH | 12/13/2024 | $363,870 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01GM148490 | Decoding the metabolic requirements for vertebrate appendage regeneration | 000 | 3 | NIH | 11/27/2024 | $378,212 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI181634 | Identifying critical determinants of vaccine-induced cellular and humoral immunity from birth through childhood in HIV-exposed and unexposed children | 000 | 2 | NIH | 2/13/2025 | $577,777 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AT011012 | Optimizing Response to Chronic Pain Treatments in Veterans: Identifying Key Moderators | 000 | 4 | NIH | 1/24/2025 | $24,110 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31DA059262 | Exploration of the unique neurobehavioral profile of sequential opioid-stimulant polysubstance use disorders | 000 | 2 | NIH | 1/27/2025 | $45,255 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH124975 | 1/3 Lay-delivered Behavioral Activation in Senior Centers | 000 | 5 | NIH | 11/22/2024 | $474,208 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K23HL151801 | Assessing and Promoting Resilience in Adults with Adult Congenital Heart Disease | 000 | 5 | NIH | 12/10/2024 | $184,413 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH104450 | Phasic dopamine and symptom domains of mental illness | 001 | 11 | NIH | 3/12/2025 | $630,248 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258997 | Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays | 001 | 4 | NIH | 2/14/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01CA258997 | Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays | 000 | 4 | NIH | 11/25/2024 | $547,570 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH134830 | Measuring Behavioral Health Integration in Community Health Centers to Improve Access, Equity, and Outcomes for Medicaid Enrollees | 000 | 2 | NIH | 2/14/2025 | $636,353 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01DC020707 | Behavioral and neural characteristics of adaptive speech motor control | 000 | 3 | NIH | 12/16/2024 | $442,602 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HD113455 | Improving perinatal outcomes among Kenyan pregnant women affected by HIV with an integrated STI testing model | 000 | 2 | NIH | 1/15/2025 | $555,083 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31NS141228 | Investigating the function of a ciliary protein in neural development | 000 | 1 | NIH | 12/27/2024 | $48,974 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R03AI188419 | Defining the larval repertoire of Aedes aegypti somatosensory neurons | 000 | 1 | NIH | 2/28/2025 | $75,418 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AR082814 | Expression of dystrophins with enhanced function | 000 | 1 | NIH | 1/22/2025 | $671,240 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R35GM156857 | Biophysical mechanisms underlying Drosophila renal tubule morphogenesis | 000 | 1 | NIH | 12/20/2024 | $388,750 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K22AG082712 | Microglial subpopulations that contribute to resilience to Alzheimers disease | 000 | 1 | NIH | 12/27/2024 | $188,892 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01MH139585 | Neural Dynamics of Fear Circuits in Ecological Rodent Models of Risk and Trauma | 000 | 1 | NIH | 3/12/2025 | $618,863 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K01HD116977 | Optimizing health outcomes by improving measurement of grief after amputation with a health equity approach | 001 | 1 | NIH | 2/19/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K01HD116977 | Optimizing health outcomes by improving measurement of grief after amputation with a health equity approach | 000 | 1 | NIH | 12/15/2024 | $125,679 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AG090551 | Novel Mechanisms of tau and TDP-43 synergy in Alzheimer's disease | 000 | 1 | NIH | 12/12/2024 | $757,027 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K01HG013983 | Statistical integration of single-cell eQTL studies and GWAS with application to autoimmune diseases | 000 | 1 | NIH | 1/13/2025 | $189,824 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HL172803 | Infrastructure for mentored access to CHS data and specimens | 000 | 1 | NIH | 12/25/2024 | $1,372,795 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | K99HL177347 | High-Throughput Studies of MYH7 Variant Cardiomyocytes to Identify Pathogenic Variants and Factors Governing Variable Expressivity of Hypertrophic Cardiomyopathy | 000 | 1 | NIH | 12/19/2024 | $126,306 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31HD115304 | Modeling Chromosomal Mosaicism During Early Human Embryogenesis on Microraft Array Platform | 001 | 1 | NIH | 12/13/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31HD115304 | Modeling Chromosomal Mosaicism During Early Human Embryogenesis on Microraft Array Platform | 000 | 1 | NIH | 12/13/2024 | $44,457 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31DA062403 | Genetic Characterization and Exploration of Mu-Opioid Receptor Signaling in C. elegans | 000 | 1 | NIH | 12/10/2024 | $48,974 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | F31DA062403 | Genetic Characterization and Exploration of Mu-Opioid Receptor Signaling in C. elegans | 001 | 1 | NIH | 12/10/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01HL172817 | Cell lysis-induced leukotriene synthesis activates type-2 immunity in the lung | 000 | 1 | NIH | 2/1/2025 | $880,735 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R33CA286947 | Sequence optimization for mRNA cancer therapy | 000 | 1 | NIH | 2/19/2025 | $380,337 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01NS136227 | Quantitative clinical imaging of demyelination and remyelination in ischemic stroke | 000 | 1 | NIH | 12/31/2024 | $541,109 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | R01AI183692 | Molecular determinants and functions of bacterial polysaccharide cellular localization | 000 | 1 | NIH | 2/25/2025 | $783,557 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01MH135901 | Developing Data-Driven Clinical Signatures for People Who Experience Hallucinations | 000 | 2 | NIH | 3/11/2025 | $2,139,265 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01IP001265 | IP24-045, SEAPREP: Seattle Pandemic Preparedness Cohort | 02 | 1 | CDC | 1/16/2025 | $893,037 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01IP001265 | IP24-045, SEAPREP: Seattle Pandemic Preparedness Cohort | 02 | 1 | CDC | 1/16/2025 | $0 |
| | 2025 | 2025 | UNIVERSITY OF WASHINGTON | 4333 BROOKLYN AVE NE | SEATTLE | WA | 98195-1016 | KING | USA | U01IP001265 | IP24-045, SEAPREP: Seattle Pandemic Preparedness Cohort | 01 | 1 | CDC | 12/11/2024 | $484,260 |
|
